Home > Research . Search . Country . Browse . Small Grants

PSC In The News

RSS Feed icon

Geronimus on pushing past early dismissal of her weathering hypothesis

Thompson: Censoring reading materials in prisons could lead to more, not less rebellion

"Me Too" momentum in the field of economics?

More News

Highlights

Remembering Jim Morgan, founding member of ISR and creator of the PSID

1/17/18: ISR screening and discussion of documentary "Class Divide" at Michigan Theater

Bailey et al. find higher income among children whose parents had access to federal family planning programs in the 1960s and 70s

U-M's campus climate survey results discussed in CHE story

More Highlights

Next Brown Bag

Mon, Jan 22, 2018, noon: Narayan Sastry

Michigan Institute for Clinical and Health Research (MICHR) - U-award

a PSC Research Project [ARCHIVE DISPLAY]

Investigators:   George A. Mashour, Blake J. Roessler, Brian D. Athey, David Alan Hanauer, Raymond J. Hutchinson, Daniel J. Clauw, Michael E. Geisser, Alexander Tsodikov, Claire Z. Kalpakjian, Marc A. Zimmerman, Donald Ray Vereen, Susan Lynn Murphy, David A. Williams, Robert A. Bagramian, Cleopatra Howard Caldwell, Kelley Kidwell, Michael S. Klinkman, Donna S. Shewach, Vicki Lynn Ellingrod, Julie C. Lumeng, Jorge Delva

The 2007 funding of the Michigan Institute for Clinical and Health Research (MICHR) marked the beginning of a transformation. With growing faculty engagement and federal and institutional support, the University of Michigan has evolved from a predominantly basic science research institution to one with a more comprehensive and synergistic research portfolio. In the past 4 years, extramural funding for clinical and translational research at UM has increased by 27% and since 2008 exceeds basic science funding. In total, 1,280 services have been provided to investigators; 1,950 trainees, staff and faculty have participated in educational venues; 37 trainees have completed certificate and graduate degree programs; fragmented research services have been centralized to create innovative opportunities for users; $10.2M have been distributed for pilot studies; and 52 faculty have participated in the national consortium. In the renewal period, MICHR will further this transformation by pursuing 4 overarching objectives: 1) Create the next generation of clinical and translational researchers and interdisciplinary teams, 2) Develop and enhance capacity-building services that add value, remove barriers, and maximize productivity across the translational research continuum, 3) Create new collaborations and novel approaches to accelerate the pace of driving discoveries to application that impacts health, and 4) Actively lead and contribute to national CTSA consortium activities. By 2017, we will expand education into new areas, strengthen the pipeline of translational researchers, and deploy more flexible and accessible training tools. MICHR will strengthen existing services and launch new ones to impact study start-up times and recruitment. Major informatics investments will fully integrate the needs of clinical and translational researchers into the electronic health record and IT landscape. New practice-based networks will optimize channels for bi-directional translation. Expanded evaluation will more quickly identify and disseminate best practices. We will leverage a significant amount of institutional support to achieve these goals. MICHR will be the engine of continuous improvement and innovation in the conduct of high quality, high impact clinical and translational research to advance the health of Michigan and the nation.

Funding Period: 06/01/2012 to 05/31/2017

This PSC Archive record is displayed for historical reference.

Search . Browse